Cite
HARVARD Citation
Samaniego, F. et al. (n.d.). 90Y‐ibritumomab tiuxetan radiotherapy as first‐line therapy for early stage low‐grade B‐cell lymphomas, including bulky disease. British journal of haematology. pp. 207-213. [Online].
This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
Samaniego, F. et al. (n.d.). 90Y‐ibritumomab tiuxetan radiotherapy as first‐line therapy for early stage low‐grade B‐cell lymphomas, including bulky disease. British journal of haematology. pp. 207-213. [Online].